托里斯提升了Centene的目标价格至49美元, 理由是政府医疗计划的强表现和增长前景. Truist raised Centene's price target to $49, citing strong performance and growth prospects in government health plans.

Truist Securities将Centene（CNC）的目标价从43美元上调至49美元，并在与管理层积极谈判后保持“买入”评级。 Truist Securities raised its price target for Centene (CNC) to $49 from $43 and kept its "Buy" rating after positive talks with management. 该公司指出，Centene对其运营，特别是在医疗补助和医疗保险优势项目中，获得了更强的可见度，以及稳健的财务表现和有纪律的成本管理。 The firm cited stronger visibility into Centene’s operations, particularly in Medicaid and Medicare Advantage, along with solid financial performance and disciplined cost management. 特鲁斯特强调该公司的战略重点是扩大政府卫生计划,改善数字平台,尽管部门不确定,但增强对其长期增长的信心。 Truist highlighted the company’s strategic focus on expanding government health plans and improving digital platforms, boosting confidence in its long-term growth despite sector uncertainties.